Zai Lab Limited ZLAB

NAS: ZLAB | ISIN: US98887Q1040 30/04/2025

31,69 USD (-0,47%)

(-0,47%) 30/04/2025

Grafiek Zai Lab Limited

Grafiek Zai Lab Limited

1 dag1d -0,47%
1 week1w -6,24%
1 maand1m -15,02%
3 maanden3m 15,74%
6 maanden6m 4,04%
1 jaar1j 99,31%
5 jaar5j -47,55%

donderdag 8 mei 2025, 13:00

Kwartaalcijfers (1ste kwartaal)

Zai Lab Limited in het nieuws

Toon enkel gratis nieuws

25 juli 2022 · Qiming's Portfolio Company InventisBio Lists on STAR Market · Persbericht

11 juli 2022 · Qiming Venture Partners Announces Closing of Funds Totaling US$3.2 Billion · Persbericht

13 april 2022 · Qiming's Nisa Leung, Duane Kuang Named on 2022 Forbes Midas List · Persbericht

9 november 2021 · Blueprint Medicines and Zai Lab Announce Strategic Collaboration and License Agreement for BLU-945 and BLU-701 in Greater China · Persbericht

25 augustus 2021 · Zhongchao Inc. Expands Patient Management Business to Ovarian Cancer Market · Persbericht

1 juni 2021 · Mirati Therapeutics and Zai Lab Enter Into a Collaboration to Develop and Commercialize Adagrasib in Greater China · Persbericht

18 februari 2021 · Zai Lab to Announce Full-Year 2020 Financial Results on March 1, 2021 · Persbericht

28 januari 2021 · Zai Lab Announces Upcoming Presentations in February Investor Conferences · Persbericht

11 januari 2021 · Turning Point and Zai Lab Broaden Collaboration · Persbericht

6 januari 2021 · argenx and Zai Lab Announce Strategic Collaboration for Efgartigimod in Greater China · Persbericht

Profiel Zai Lab Limited

Fabricage van farmaceutische preparaten

Gezondheidstechnologie

Werknemers: 258

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe